Diabetic Endocrine Eye Diseases
Date: 28/02/2019
Venue: 1908 Cronulla, 1/15 Surf Road, CRONULLA, NSW, 2230
Provider: Southeastern Eye Care
Contact: Emma Robson, [E] info@seecare.com.au, [P] 95254747
Learning Objectives
- Dr Hughie Tsang: At the completion of the CPD activity participants should be able to, identify potential pituitary pathology, identify thyroid eye disease signs, symptoms and management, identify endocrinological association of common eye symptoms, and further understand conditions that have an endocrinological etiology or manifestation of eye findings from endocrinology management related to diabetes.
- Dr Belinda Leong: At the completion of the CPD activity participants should be able to identify risk factors for the presence or progression of diabetic retinopathy, grade stages of non-proliferative diabetic retinopathy, and distinguish features of proliferative diabetic retinopathy.
- Dr Bobby Chan: At the completion of the CPD activity, participants will have a greater understanding of diabetic retinopathy and its associated risk factors and how this can impact retinopathy.
Max points awarded: 7.00
Session Information
Name |
---|
Other Endocrine Diseases |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
3.00 |
Name |
---|
Diabetic Retinopathy - Updated Protocol 2018 RANZCO |
Activity Type |
Face to Face with Assessment |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
3.00 |
Name |
---|
Diabetic Endocrine |
Activity Type |
Non Clinical |
Therapeutic? |
No |
Manufacturer/Supplier? |
No |
Points for attending & Passing Assessment |
1.00 |
Name | Activity Type | Therapeutic? | Manufacturer/ Supplier? | Points for attending & Passing Assessment |
---|---|---|---|---|
Other Endocrine Diseases | Face to Face with Assessment | No | No | 3.00 |
Diabetic Retinopathy - Updated Protocol 2018 RANZCO | Face to Face with Assessment | No | No | 3.00 |
Diabetic Endocrine | Non Clinical | No | No | 1.00 |